Ropes & Gray has advised Zenas BioPharma on the transaction, and Goodwin Procter and Maiwald GmbH have advised Royalty Pharma. Zenas BioPharma has entered into a...
Zenas BioPharma Secures Up to $300 Million Synthetic Royalty Financing from Royalty Pharma
MBX Biosciences’ $187.7 Million IPO
Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters. MBX Biosciences, Inc....
Merck’s $680 Million Acquisition of Harpoon Therapeutics
Evercore Group L.L.C. acted as financial advisor to Merck in this transaction and Covington & Burling LLP acted as its legal advisor. Centerview Partners LLC acted...